CoreMap, a Burlington, Vt.-based developer of a cure for atrial fibrillation (AF), raised $3m in Series A financing concurrently with a $20 million Series B financing. The financing includes a diverse group of strategic, institutional, venture and individual partners including Qure Ventures and Russ Scully of The Fund at Hula. The financing will be used [...]The post CoreMap Closes $23M Series B Financing appeared first on FinSMEs.